Predicting the risk of high-grade precancerous cervical lesions based on high-risk HPV typing in Changsha China

被引:0
|
作者
Xiao, Yaling [1 ,2 ]
Liu, Rangjiao [3 ,4 ]
Wang, Shaobo [3 ]
Wang, Yuxiang [3 ]
Miao, Weimin [4 ]
Chen, Meiwei [3 ]
Liu, Xiaowen [1 ,2 ]
Chen, Yan [1 ,2 ]
Wen, Yongchun [1 ,2 ]
Deng, Zhongping [4 ]
Dai, Lizhong [4 ]
Mao, Zenghui [1 ,2 ]
He, Jun [1 ,2 ]
机构
[1] Hunan Prov Key Lab Reg Hereditary Birth Defects Pr, Changsha, Peoples R China
[2] Hunan Normal Univ, Changsha Hosp Maternal & Child Hlth Care, Changsha, Peoples R China
[3] Sanway Clin Lab, Changsha, Peoples R China
[4] Sansure Biotech Inc, Changsha, Peoples R China
关键词
HPV typing; TCT; Colposcopy; Biopsy; Cervical lesions; Pathogenicity risk; HUMAN-PAPILLOMAVIRUS; CANCER;
D O I
10.1186/s12905-025-03562-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundPersistent infection with high-risk human papillomavirus (HPV) is a significant risk factor for cervical cancer. HPV typing and cytology are conducted in women of appropriate age to assess the risk of cervical lesions and to guide the need for further diagnostic procedures such as colposcopy, cervical biopsy, or treatment. This article explores methods to predict the risks of high-grade precancerous cervical lesions based on high-risk HPV typing.MethodsWe conducted a retrospective analysis of HPV typing data from 158,565 women, including 19,707 who underwent ThinPrep cytologic testing (TCT), 7,539 who had colposcopy examinations, and 4,762 who had biopsies. We evaluated the sensitivity, specificity, and risk parameters of high-grade lesions associated with high-risk HPV types.Results(1) The overall prevalence of HPV infection was 17.89%, with the most prevalent types being HPV52 (4.44%), HPV58 (2.10%), HPV53 (1.96%), HPV81 (1.85%), HPV42 (1.75%), and HPV16 (1.44%). (2) The sensitivity and specificity of detecting high-grade lesions in TCT, colposcopy, and biopsy, based on high-risk HPV typing, demonstrated a strong linear correlation with the infection rate of each type. (3) HPV16 was confirmed to have a higher risk of CIN2 + in biopsies using a self-defined risk parameter. (4) The top five HPV types with the highest PPVs and pathogenicity risks in biopsies were HPV45, HPV16, HPV58, HPV33, and HPV18.ConclusionIn Changsha, China, HPV52, HPV58, and HPV53 were the most prevalent and contributed significantly to high-grade lesions. After adjusting for infection rates, a self-defined risk parameter was proposed as a measure of the intrinsic risks of high-grade lesions associated with high-risk HPV types. Focused monitoring of prevalent high-risk HPV types such as HPV45, HPV16, HPV58, HPV33, and HPV18, which show the highest pathogenicity risks, is recommended in our region.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Multiple high-risk HPV infections probably associated with a higher risk of low-grade cytological abnormalities but not with high-grade intraepithelial lesions of the cervix
    Tong Tong
    Di Su
    Qi Yang
    Kun Yang
    Yuqi Liu
    Qun Wang
    Tian Tian
    World Journal of Surgical Oncology, 22
  • [22] High Rates of High-Grade Cervical Dysplasia in High-Risk Young Women With Low-Grade Cervical Cytology
    Daily, Laura R.
    Erickson, Britt K.
    Pasko, Daniel N.
    Straughn, J. Michael
    Huh, Warner K.
    Leath, Charles A., III
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2018, 22 (03) : 207 - 211
  • [23] Risk of cervical lesions in high-risk HPV positive women with normal cytology: a retrospective single-center study in China
    Wang, Zhiling
    Liu, Ting
    Wang, Yunjian
    Gu, Ying
    Wang, Hui
    Liu, Jingkang
    Cui, Baoxia
    Yang, Xingsheng
    INFECTIOUS AGENTS AND CANCER, 2020, 15 (01)
  • [24] Coinfection of High-Risk Human Papillomavirus and Lower Genital Tract Pathogens in the Development of High-Grade Cervical Lesions
    Zhong, Hui
    Tong, Yao
    Lin, Haifeng
    Mao, Xiaodan
    Dong, Binhua
    Wu, Zhihui
    Chen, Huiyu
    Sun, Pengming
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2020, 2020
  • [25] High-risk HPV detection and genotyping by APTIMA HPV using cervical samples
    Pyne, Michael T.
    Hamula, Camille L.
    Tardif, Keith
    Law, Christian
    Schlaberg, Robert
    JOURNAL OF VIROLOGICAL METHODS, 2015, 221 : 95 - 99
  • [26] Establishment and validation of a risk prediction model for high-grade cervical lesions
    Sheng, Binyue
    Yao, Dongmei
    Du, Xin
    Chen, Dejun
    Zhou, Limin
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2023, 281 : 1 - 6
  • [27] Anal High-risk HPV and Liquid-based Cytology of Immunocompetent Brazilian Women with Genital High-risk HPV
    Rego Leopoldo Melo, Karla Maria
    Eleuterio Junior, Jose
    Coelho Peixoto, Raquel Autran
    Fernandes Reboucas, Karinne Cisne
    Nunes Eleuterio, Renata Mirian
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2022, 44 (03): : 280 - 286
  • [28] Self- and physician-collected high-risk human papillomavirus (HPV) testing to detect high-grade cervical lesions among Thai women
    Phoolcharoen, Natacha
    Areeruk, Wilasinee
    Kantathavorn, Nuttavut
    Tiyayon, Jitima
    Chittithaworn, Suwicha
    Wetcho, Thanita
    Satitniramai, Sikarn
    Khomphaiboonkij, Uraiwan
    Pitakkarnkul, Supakorn
    Termrungruanglert, Wichai
    Srisomboon, Jatupol
    Tangjitgamol, Siriwan
    Thai Gynecologic Cancer Society Research Group, Thai Gynecologic Cancer Society
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (09) : 1354 - 1358
  • [29] Predicting the risk of esophageal high-grade lesions in opportunistic screening Response
    He, Zhonghu
    Ke, Yang
    GASTROINTESTINAL ENDOSCOPY, 2020, 92 (05) : 1137 - 1138
  • [30] RNA-based high-risk HPV genotyping and identification of high-risk HPV transcriptional activity in cervical tissues
    van den Heuvel, Corina N. A. M.
    Loopik, Diede L.
    Ebisch, Renee M. F.
    Elmelik, Duaa
    Andralojc, Karolina M.
    Huynen, Martijn
    Bulten, Johan
    Bekkers, Ruud L. M.
    Massuger, Leon F. A. G.
    Melchers, Willem J. G.
    Siebers, Albert G.
    Leenders, William P. J.
    MODERN PATHOLOGY, 2020, 33 (04) : 748 - 757